Industry committee  I don't agree with this statement out of context.

Industry committee  In short, I have a two-pronged response. I think we need a framework for this investment. We can't be jumping up to lobbying groups, and there are many mouths coming forward to committees like this to make the appropriate asks. We as a country have to understand the role that eac

Industry committee  Thank you for the question, Mr. Vincent. It's a very important one. I think we have made, as a country, an excellent start. We have created salary programs, the Canada research chair program; we have provided magnificent laboratory facilities for those individuals we actually tr

Industry committee  I think we have to build on where we already have capacity. And I think you've nutted it; we find ourselves in a situation where we are a mile wide and an inch deep and, as a consequence, not making hay in any arena. Discovery research is the pipeline. All of the good stuff we

Industry committee  Can I just finish the sentence, Mr. Chair?

Industry committee  The scientists at research-intensive hospitals are paid for by philanthropy.

Industry committee  No.

Industry committee  At this juncture I would not recommend investing more money without a plan and a framework within which to invest that money. I think that's the challenge we have been enjoying over the last decade. Investments into the health research enterprise over the last 15 years in Canada

Industry committee  That, of course, is an excellent question. And just to manage your expectations, the model is contemplating doing precisely that exercise. That exercise has not been completed. The model right now is a descriptive model, and our goal is to make it a prescriptive model—and it is

Industry committee  Our chair is so draconian. I'm sensing the hook coming from the front of the table in a moment. We're a system out of balance and failing to capitalize on the innovation advantage afforded by federal investments in world-class research, people, and facilities. Indeed, these inve

Industry committee  Thank you very much, Mr. Chair and members of the committee. My name is Michael Julius. I'm the chair of Research Canada and vice-president of research for Sunnybrook Health Sciences Centre in Toronto, Ontario. It's a pleasure for Deborah Gordon-El-Bihbety, president and CEO of